Pegaptanib

Pegaptanib (marketed as Macugen) is a targeted therapy for wet age-related macular degeneration (AMD). It is a pegylated aptamer that binds to vascular endothelial growth factor (VEGF) and blocks its activity. This helps to mitigate the formation of abnormal blood vessels in the eye, which can cause vision loss. Pegaptanib is administered as an intravitreal injection (injected into the eye) once every six weeks.

Pegaptanib, also known by the brand name Macugen, is a medication used to treat a specific eye condition called neovascular age-related macular degeneration (wet AMD) [1, 2, 3]. Here's a breakdown of its key aspects:

  • Type: Anti-angiogenic agent [1, 2, 3]. This means it targets and inhibits the growth of new blood vessels.
  • Function: Wet AMD is characterized by abnormal blood vessel growth in the macula, the central part of the retina responsible for sharp central vision. Pegaptanib works by blocking a protein called vascular endothelial growth factor (VEGF), which plays a key role in this abnormal blood vessel growth [1, 2, 3]. By inhibiting VEGF, Pegaptanib helps slow down the progression of wet AMD and prevent vision loss.

Important to Know:

  • Pegaptanib is not a cure for wet AMD, but it can help slow down vision loss and improve visual function in some cases [1, 2, 3].
  • It's administered as an injection directly into the vitreous cavity (the jelly-like center) of the eye by a qualified ophthalmologist (eye doctor) [1, 2, 3].
  • Treatment with Pegaptanib typically involves a series of injections at regular intervals, as determined by your doctor [1, 2, 3].

Here are some additional things to keep in mind about Pegaptanib:

  • Side effects: Potential side effects can include eye pain, bleeding in the eye, inflammation, decreased vision, and floaters (seeing spots or cobwebs in your vision) [1, 2, 3]. It's crucial to report any side effects to your ophthalmologist.
  • Alternatives: There are other medications available for treating wet AMD, and the best choice depends on your individual situation. Your doctor will discuss the options with you [1, 2, 3].
Anatomical Therapeutic Chemical Classification
S - Sensory organs
S01 Ophthalmologicals
S01L - Ocular vascular disorder agents
S01LA Antineovascularisation agents
External Links